The European Medicines Agency Clinical Data Website Enables Insights I | OAJCT
Full article: Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
Latest hypertension research to inform clinical practice in Asia | Hypertension Research
Pharmaceutical application and development of fixed-dose combination: dosage form review | SpringerLink
Decoding the ban on irrational fixed-dose combination drugs in India | ORF
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics - ScienceDirect
Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis - The American Journal of Medicine
Evaluation of synergism in drug combinations and reference models for future orientations in oncology - ScienceDirect
Challenges and opportunities to include patient‐centric product design in industrial medicines development to improve therapeutic goals - Timpe - 2020 - British Journal of Clinical Pharmacology - Wiley Online Library
OVERVIEW OF COMMENTS RECEIVED ON DRAFT GUIDELINE ON FIXED COMBINATIONS – REV 1
Annex 5 Guidelines for registration of fixed-dose combination medicinal products - PDF Free Download
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia | SpringerLink
Guideline on clinical development of fixed combination medicinal products
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial -
Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects | Nature Communications
Pharmaceutical application and development of fixed-dose combination: dosage form review | SpringerLink
Guideline on Fixed Combinations
Guideline on clinical development of fixed combination_ public consultation
Guideline on clinical development of fixed combination medicinal products - The IMPT
A Review on Drug Combination Strategy for Pharma Life Cycle Management
What you need to know about fixed-dose combinations - NPS MedicineWise
Guideline on pharmaceutical fixed combination products
FDC GDL _overview of comments
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Nature Medicine
